These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 20932599)
1. Hepcidin in human iron disorders: therapeutic implications. Pietrangelo A J Hepatol; 2011 Jan; 54(1):173-81. PubMed ID: 20932599 [TBL] [Abstract][Full Text] [Related]
2. Regulation of hepcidin and iron-overload disease. Lee PL; Beutler E Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694 [TBL] [Abstract][Full Text] [Related]
3. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Ganz T; Nemeth E Hematology Am Soc Hematol Educ Program; 2011; 2011():538-42. PubMed ID: 22160086 [TBL] [Abstract][Full Text] [Related]
5. The molecular basis of iron overload disorders and iron-linked anemias. Kaplan J; Ward DM; De Domenico I Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258 [TBL] [Abstract][Full Text] [Related]
6. Hepcidin and iron homeostasis. Ganz T; Nemeth E Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005 [TBL] [Abstract][Full Text] [Related]
7. Hepcidin and disorders of iron metabolism. Ganz T; Nemeth E Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198 [TBL] [Abstract][Full Text] [Related]
8. Iron and hepcidin: a story of recycling and balance. Camaschella C Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154 [TBL] [Abstract][Full Text] [Related]
9. Manipulation of the hepcidin pathway for therapeutic purposes. Fung E; Nemeth E Haematologica; 2013 Nov; 98(11):1667-76. PubMed ID: 24186312 [TBL] [Abstract][Full Text] [Related]
10. Iron regulation by hepcidin. Zhao N; Zhang AS; Enns CA J Clin Invest; 2013 Jun; 123(6):2337-43. PubMed ID: 23722909 [TBL] [Abstract][Full Text] [Related]
11. Hepcidin and iron disorders: new biology and clinical approaches. Arezes J; Nemeth E Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966 [TBL] [Abstract][Full Text] [Related]
13. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. Preza GC; Ruchala P; Pinon R; Ramos E; Qiao B; Peralta MA; Sharma S; Waring A; Ganz T; Nemeth E J Clin Invest; 2011 Dec; 121(12):4880-8. PubMed ID: 22045566 [TBL] [Abstract][Full Text] [Related]
14. Hepcidin in beta-thalassemia. Nemeth E Ann N Y Acad Sci; 2010 Aug; 1202():31-5. PubMed ID: 20712769 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Finberg KE; Whittlesey RL; Fleming MD; Andrews NC Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: The role of hepcidin in iron homeostasis--implications for hemochromatosis and other disorders. Pietrangelo A; Trautwein C Nat Clin Pract Gastroenterol Hepatol; 2004 Nov; 1(1):39-45. PubMed ID: 16265043 [TBL] [Abstract][Full Text] [Related]
18. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680 [TBL] [Abstract][Full Text] [Related]
19. Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal. Sohn YS; Mitterstiller AM; Breuer W; Weiss G; Cabantchik ZI Br J Pharmacol; 2011 Sep; 164(2b):406-18. PubMed ID: 21091647 [TBL] [Abstract][Full Text] [Related]